Coloradans warned of counterfeit weight-loss drugs, more Health Headlines Grand Junction Daily Sentinel
Month: March 2025
Ozempic and other GLP-1s are trending in Hollywood — and cardiology departments – Northern Public Radio (WNIJ)
Ozempic and other GLP-1s are trending in Hollywood — and cardiology departments Northern Public Radio (WNIJ)
The Skinny Jab Revolution review: Kathryn Thomas shines an intelligent light on ‘weight-loss wonder’ Ozempic – The Irish Times
The Skinny Jab Revolution review: Kathryn Thomas shines an intelligent light on ‘weight-loss wonder’ Ozempic The Irish…
AbbVie Enters The Obesity Arena. And It’s Not With A GLP-1. – Investor’s Business Daily
AbbVie Enters The Obesity Arena. And It’s Not With A GLP-1. Investor’s Business Daily
Retatrutide melts fat fast but at a cost warn experts – Diabetes.co.uk
Retatrutide melts fat fast but at a cost warn experts Diabetes.co.uk
AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal – Investopedia
AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal Investopedia
GLP-1 Drugs Offer More Than Weight Loss and Glucose Control – Medscape
GLP-1 Drugs Offer More Than Weight Loss and Glucose Control Medscape
Conagra ‘GLP-1 Friendly’ Badge Taps the Weight Loss Drug Craze – Packaging Digest
Conagra ‘GLP-1 Friendly’ Badge Taps the Weight Loss Drug Craze Packaging Digest
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’ – PR Week
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’ PR Week
AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic – MedCity News
AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic MedCity News